Press Coverage

ISMP Issues Warning about Possible Safety Issues with Newly Authorized Antiviral

News item covers ISMP’s alert regarding Paxlovid for treatment of COVID-19, highlighting that a dose reduction is necessary for patients with moderate renal impairment.

For the full text, visit APhA online.

More News

I knew if I wanted to become a subject matter expert and advance through the ranks of medication safety specialists, I needed to align myself with the organization considered the gold standard for medication safety information.